6. Absorption rate and bioavailability of acetylsalicylic acid and its calcium salt after oral and rectal administration 1.
INTRODUCTION
The clinical importance of acetylsalicylic acid as an effective mild analgesic has led to numerous studies concerning pharmacokinetics in man (SMITH and SMITH 1966; ROWLAND and RIEGELMAN 1968 ; VAN GINNEKEN 1976) . The plasma concentration-time curve of acetylsalicylic acid after intravenous administration of 65o mg acetylsalicylic acid was described by a bi-exponential equation. The half-life for the rapid component was 2-5 min, while that of the second component ra.nged from 13-19 min. The average total body plasma clearance in man was 65o ml/min, while the apparent volume of distribution was found to be less than IO 1 (ROWLAND and RIEGELMAN 1968 ) .
After a single oral dose of 650 mg acetylsalicylic acid, dissolved in 250 ml of water, absorption was reported to be rapid and complete. Peak plasma levels of acetylsalicylic acid were reached within 2o min (ROWLAND et al. 1972 ) .
These levels then declined rapidly, with only small amounts remaining after 2 h. Plasma levels ,of the metabolite salicylate rose rapidly and exceeded those o,f acety!salicylic acid because of slower elimination rather than differences in distribution (ROWLAND and RIEOE~ MAN 1968 ) . Maximal plasma levels were reached after about 6o min. The eliminati0n half-life of salicylic acid was abou t 2.5: h and the volume of distribution was smaller than IO 1 (VAN GINNEKEN !976)-Comparison of the area under the acetylsalicylic acid plasma c0n, centration-time curve following intravenous and oral routes indicated that only 68 percent of the oral dose reached the circulation intact. Since the area under the salicylic aci d c,u, rve was the same following either route of adminaIn honour of Professor POLDERMAN on the occasion of his retirement. 2Laboratorium voor Farmacologie en Farmacotherapie, Ant. Deusinglaan z, 9713 AW Gr0ningen, The Netherlands.. istration, excluding incomplete absorption from the gastro-intestinal (G0 tract, first pass metabolism by liver or gut wall was supposed to occur (ROWLAND et aL I967) .
Rectal absorption of acetylsalicylic acid has only been evaluated monitoring plasma or urine concentrations of the metabolite salicylate. The influence of the chemical composition of the suppository vehicle on the in vitro release and the in vivo absorption has been studied by many workers (CACCHILO .and HASSLER ~954; SAMELIUS and .~STROM I958; NEUWALD and KUNZE 1964; LOWENTHAL et al. z970; GIBALDI and GRUNDHOFER I975) . In general it was concluded that the composition of the fatty bases was only of secondary importance h, vivo, in contrast to the laboratory in vitro tests. Particle size reduction of acetylsalicylic acid did increase the absorption rate (CID I974; PARROT I975) , although the underlying mechanism of this phenomenon was not established. found that, in accordance with the results of NEUWALD and KUNZE (I964), absorption of acetylsalicylic acid and calcium carbaspirin (a soluble complex of calcium acetylsalicylate with urea, Ascal | followed similar patterns. When compared with oral administration of an equal dose of acetylsalicylic acid, rectal absorption was reported to be slower (COLDWELL et al. I969; GIBALDI and GRUNDHOFER I975; SUPERSTINE et aL I978) , or equally fast (CACCHILO and HASSLER I954; SA-MELIUS and ~,STR6M I958; PARROT I97I ). However, the formulation of the rectal dosage forms used in these studies was rather different and acetylsalicylic acid concentrations in plasma were not measured. No distinction was made between the release from the dosage form and the rectal absorption process, and consequently it remained uncertain whether one of the two processes was rate determining.
The aim of our study was to establish the character of the rectal absorption process of acetylsalicylic acid, by measuring plasma concentrations of acetylsalicylic acid and salicylic acid, in volunteers. In addition rectal absorption of the watersoluble calcium salt was studied. For comparison an orally administered solution of acetylsalicylic acid in water wasincluded.
EXPERIMENTAL

Dosage forms
Acetylsalicylic acid (usp xlx, Aldrich) and calcium acetylsalicylate (Ascal | ACF chemiefarma Nv) were used.
A coarse (125-25o/2m) fraction of acetylsalicylic acid and calcium acetylsalicylate was separated by sieving (Alpine model A 200LS). A micronised ( < 2o~tm) fraction was prepared by grinding the material in a jet mill. The powders were mixed with a molten base Witepsol H 15 (Interpharm), poured into brass moulds (3 ml) and stored in the refrigerator for at least one night before use. The weight of thesuppositories was adjusted exactly to 2.8 g, and they contained t7.I4 % w/w acetyisalicylic acid (500 mg) or 22.85 % w/w calcium acetylsalicylate (640 rag).
An acid micro-enema was prepared, containing 500 mg of micronised (< 2oltm) acetylsalicylic acid, suspended in IO ml of a medium, containing 0.5% methylcellulose 400 cP (Ned. Pharm. Ed. Vl) in citrate/phosphate buffer (pH = 4.0). The buffer was prepared by dissolving t2.6 g citric acid monohydrate (Merck p.a.) and 28.6 g disodium hydrogen phosphate 12-hydrate (Merck p.a.) in looo ml of distilled water. A neutral micro-enema was prepared by dissolving 500 mg of acetylsalicylic acid in Io ml of a medium, containing 0.5% methylcellulose 400 cP in distilled water. The latter solution was prepared with the aid of 1.312 g sodium hydrogencarbonate (Merck p.a.) and 0-933 g citric acid monohydrate. The pH of this microenema was 7.0.
A micro-enema containing 640 mg calcium acetylsalicylate was prepared by dissolving the compound in Io ml of medium, which consisted of 0. 5 % methylcelluiose 400 cP in distilled water. The pH of the solution was adjusted to pH 7.0 using a o. I M solution of sodium hydroxide. The oral dosage form was a 2o0 ml aqueous solution, containing 500 mg of acetylsalicylic acid.
In vitro determhzations
The release of acetylsalicylic acid and calcium acetylsalicylate from the fatty dosage forms at 37~ was determined using a release apparatus with a fixed lipid/water contact area, described by SCHOONEN et al. (I979) . The results are mean values of four runs.
Human experiments
Eight healthy human subjects, female and male, ranging in age from 23-37 years and in body weight from 55-70 kg, participated in the cross-over study at 2-week intervals over a period of 3 months. No drugs were taken prior or during the study. The experiments were initiated in the morning and the volunteers did not take any food during the experiments. They were asked to remain in a sitting
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Vol. 1-1979 Pharmaceutisch Weekblad Scientific Ediaon 24.5: position. No discomfort following application of any rectal dosage forms was reported by the volunteers. The micro-enemas were administered using a: plastic disposable syringe to which a plastic application tube was connected. The tube was introduced in the rectal lumen enabling quantitative emptying of the syringe into the rectum.
Bloodsamples of io ml were taken using Venoject tubes (Terumo Corporation) with I5 mg at ~o, 20, 3 o, 40, 50, 60, 75, 90, i2o, 18o and 240 min. To the bloodsamples 50 ~tl of a solution, containing 50% w/w potassium fluoride, was immediately added. The bloodsamples were stored in an ice bath. Plasma was obtained by centrifugation and was frozen until the time of analysis.
Determination of acetylsalicylic acid and salicylic acid in plasma
Acetylsalicylic acid and salicylic acid concentrations in plasma were estimated by the method of extraction of the drug from acidified plasma into chloroform. After re-extraction with an aqueous buffer solution the eluent was analysed by high-pressure liquid chromatography.
Standard solutions
A 0.0o 7 M buffer solution was prepared by dissolving o.716 g disodium hydrogen phosphate I2-hydrate (Merck p.a.) and 0.644 g sodium dihydrogen phosphate z-hydrate (Merck p.a.) in IOOO ml of distilled water. The pH was 6.6.
A 0.007 M buffer solution was prepared by dissolving i.9o7 g disodium hydrogen phosphate t2-hydrate and o.184 g sodium dihydrogen phosphate z-hydrate in tooo ml of distilled water. The pH was 7.4.
A 0.07 M buffer solution was prepared by dissolving I9.O 7 g disodium hydrogen phosphate 12-hydrate and 1.84 g sodium dihydrogen phosphate 2-hydrate in IOOO ml of distilled water. The pH was 7.4.
A standard solution was freshly prepared by dissolving 40 mg acetylsalicylic acid and 80 mg salicylic acid (Ned. Pharm. Ed. viii) in IOO ml 0.07 M buffer solution (pH 7.4.).
An internal standard solution was prepared by dissolvZ ing 20.00 mg 4-methoxyphenylacetic acid (Aldrich p.a 0 in tooo ml of distilled water.
The standard solutions were stored in the refrigerator at 4~
Apparatus
A liquid chromatograph (Waters Associates) was used in this study, equipped with an uv detector (model 440) set at 254 nm. The column (30 cm x 4.6 mm) was packed with Nucleosil ioCI8 (Macherey-Nagel & Co.). Analyses were performed using a mobile phase of to% methanol (Merck) in 0.007 M buffer solution (pH 6.6) at a flow-rate of 2.0 ml/min.
Procedure
To I.o ml plasma in a IO ml tapered stoppered tube I.O ml of a 1o% w/v KHSO4 solution in distilled water, i.o ml of the internal standard solution and IO.O ml chloroform (Merck p.a.) were added. After shaking for IO min the content of the tube was centrifuged for 5 min at 4000 rpm and the aqueous layer was removed by aspiration. To 5.0 ml of the chloroform layer in a io ml tapered stoppered tube I.O ml 0.007 M buffer solution pH 7-4 was added.
After shaking for 5 min and centrifuging for 5 min at 4000 rpm Ioo/~1 of the aqueous layer was injected into the HrLC. The retention times of acetylsalicylic acid; salicylic acid .and 4-methoxyphenylacetic acid were 2.3, 3.0 and 3.9 rain respectively. The ratio of the peak height of the sample components to that of the internal standard was used to calculate concentrations of acetylsalicylic acid and salicylic acid, based on calibration curves prepared from spiked plasma samples (Table x) . The overall (extraction) recove~ from plasma was determined for seven different concentrations and was found to be essentially complete. With I.O ml plasma Samples the method can be used to determine concentrations as low as 0.3 #g/ml for acetylsalicylic acid and salicylic acid. 
Pharmacokinetic parameters
The absorption was characterised by two parameters: the peak concentration (C,,ax) and the peak concentration time (tmax)-The areas under the plasma concentration time curves were determined by the trapezoidal rule. For acetylsalicylic acid this surface was estimated from t = o to t = I2o min, for salicylic acid from t = o to t = 240 min. Relative bioavailability was determined using the equation:
Statistical analysis
Differences in plasma acetylsalicylic acid levels after administration of the various dosage forms were tested for statistical significance by STUDm~T'S 't' test (P< 0.05 two sided). In pairs, the concentrations of acetylsalicylic acid were compared after it had been established that these concentrations were normally distributed applying SnAPmO-WILK'S test (P< 0.05).
RESULTS AND DISCUSSION
Comparison of absorption after oral and rectal administration of aqueous dosage forms containing acetylsalicylic acid.
The mean plasma concentrations of acetylsalicylic acid in eight subjects after oral and rectal administration of a dose of 500 mg acetylsalicylic acid in aqueous solutions are given in Fig more rapidly after oral than after rectal administration. LEVY and AMSEL (I966) concluded that, in accordance with the pH partition hypothesis for drug absorption, the rate of acetylsalicylic acid absorption into the systemic circulation is dependent upon the concentration of the unionised acid. After oral administration of a solution Of acetylsalicylic acid (PKa = 3.5) the drug will be largely protonated in the acid medium of the stomach. As a consequence the absorption circumstances seem to be rather favourable. Although many factors, such as stomach emptying, gastric blood flow, amount of fluid in the stomach and degree of intestinal motility, could limit the rate and extent of acetylsalicylic acid absorption (ROWLAND et a/. I972), the mean peak plasma level of 9.o/~g/ml was reached already about 20 min after administration (Table IXA, Figure I ). Since the pH of the rectal micro-enema dosage form was 7.0, it can be concluded that, apart from differences in absorption surface, dissociation of the drug in the human rectum (pH is 7-8) is higher than in the stomach and gut, resulting in less favourable absorption conditions. To test this pH influence on the absorption rate and relative bioavailability, 5o0 mg acetylsalicylic acid was rectally administered in the form of a micro-enema (io ml) with a pH of 4.o. The mean plasma concentrations of acetylsalicylic acid are given in Figure i and Table  hA . It appeared that the rate of uptake was significantly (P < 0.o5) more rapid than in the case of the IO ml micro-enema with a pH of 7.o. Relative bioavailability was also found to be significantly (P < 0.05) higher. Yet, compared with the oral dosage form, absorption rate after administration of the acid micro-enema was significantly (P < 0.05) lower. It is likely that this remaining difference is mainly due to differences in absorption surface between both routes of administration. This is supported by the results as shown in Figure 2 . Micro-enemas,
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Pharmaceutisch Weekblad II4-I979 containing 5oo mg acetylsalicylic acid suspended in different volumes of water (pH = 4.0) were rectally administered to one subject. Comparing Figure I and Figure 2 it is apparent that after rectal administration of the 20 ml suspension a plasma profile comparable with that after oral administration of 500 mg acetylsalicylic acid is obtained. Since the rectal suspensions possess both the saturation concentration (solubility in water is i in Ioo at 37~ it is likely that the difference in absorption rate, as can be observed from Figure 2 , is due to a difference in absorption area rather than to a difference in the amount of drug in solution.
Calcium acetylsalicylate VAN GINNEKEN (Z976) concluded that the water soluble calcium acetylsalicylate was rapidly and completely absorbed after oral administration. However, with rectal use the'situation is quite different since the neutral pt-I of the calcium salt solution will not favour rapid absorption (Fig. 3) . Indeed it appeared that an equimolar dose (64o mg) of the salt, dissolved in a micro-enema (IO ml, pH 7.o), resulted in poor absorption. In addition it was observed that ~e plasma concentrations of acetylsalicylic acid after administration of the calcium salt were significantly (P < o.o5) lower as compared with the sodium salt micro-enema dosage form. It is uncertain whether this difference is due to the formation of a nonabsorbable complex in which calcium plays a role. However, if the pH of the calcium acetylsalicylate micro-enema was decreased to pH 4.o absorption rate did increase markedly (Fig. 3) . Plasma profile was now found to be equal, comparing the acid micro-enemas dosage forms with and without calcium at pH 4.o.
Suppositories
A substantial difference in release rate in vitro could be observed between acetylsalicylic acid and its calcium salt from a fatty vehicle. In earlier studies we concluded that dependent on the water solubility of the drugs under study, particle size of a drug, suspended in a fatty suppository base, can affect the release in vitro (scnoor,rEN et al. I976, I979 ). The influence of particle size reduction of slightly soluble drugs on the release rate proved to be much less than in the case of readily water soluble drugs. This is indeed illustrated for acetylsalicylic acid and its calcium salt in Figure 4 . The possible implications of these in vitro data for the situation in vivo with respect to the rate and extent of absorption are shown in Figure 5 .
The following observations were made. i. Administration of the micronised (< 2o/~m) acetylsalicylic acid rectal dosage form did result in significantly (P < o.o5) higher plasma concentrations compared with the coarse (I25-25o ~m) particles dosage form. This observation contrasts with our in vitro data (Figure 4 ), but it is in agreement with the observations from an in vivo study with paracetamol ( . Mean plasma concentrations of acetylsalicylic acid (ASA) after rectal administration of5oo mg acetylsalicylic acid with different particle sizes, and 640 mg calcium acetylsalicylate, particle size I25-25o ~m, suspended in Witepsol H I5 suppositories (4 ml).
AS A plasma conc.~g.mt-1 )-" ASA 500 mg 9" .~'. ... ".. al. i979d ), in which the drug was rectally administered in the form of fatty suppositories using various classes of particle sizes. From this study it was learned that the release per unit surface was independent of the particle size used and the higher absorption rate observed in vivo for the smaller particles was probably caused by the larger part of the lipid/water interface that was occupied by these particles. As acetylsalicylic acid is also slowly soluble in water and is only 1.5 percent soluble in fat, the same behaviour can be expected. Therefore we concluded that the driving force for absorption of acetylsalicylic acid is determined by the part of the interface that is occupied by particles, being larger for fine particles than for coarse ones. 2. In spite of a fast release in vitro, absorption of the calcium salt (125-25o/tm) from a fatty suppository in vivo is poor. A likely explanation for this observed in vitro~in vivo discrepancy may be that, compared with the free acid, the concentration of dissolved calcium acetylsalicylate in the rectum fluid may be higher, but that the neutral pH range is unfavourable for absorption (Fig. 3) .
:r ~-
Suppositories versus micro-enemas
The mean plasma concentrations after rectal administration of a single dose of 500 mg ace.tylsalicylic acid (< 2o/~m), suspended in Witepsol Ht 5 (3 ml) are presented together with the mean plasma concentrations after rectal administration of the other dosage forms (Fig. 6a) .
Statistical analysis (P < 0.05) indicated that after administration of the suppository dosage form the C,~ax was significantly higher than after administration of the micro-enema, containing the completely dissolved acetylsalicylic acid (pH = 7.0). On the other hand the Cm~ was reached significantly later as compared with the micro-enema with pH 4.0.
The difference in Cm,, and F=~ between the neutral micro-enema and the suppository dosage form may be explained by the fact that in case of the suppository the free acid enters the rectal fluid and causes a drop in pH resulting in a relatively high concentration of undissociated acid and, as a consequence, in rather favourable absorption conditions. On the other hand, the rate difference between the acid microenema and the suppository is probably due to the fact that, as a result of the favourable PH conditions, absorption from the micro-enema occurs primarily during the first IO rain period after administration (Fig. 6a) , whereas the behaviour of the suppository in this period is characterised by the melting and spreading process in the human rectum.
Pharmaceutisch Weekblad Scientific Edition Vol. 1-1979 Acetylsalicylic acid plasma levels versus salicylic acid plasma levels In addition to the acetylsalicylic acid plasma concentrations salicylic acid plasma concentrations were followed in all experiments during 4 hours ( Table Ira) . Mean salicylic acid plasma levels after administration of the oral and rectal dosage forms are given in Figure 6b . Figures 6a and 6b show that differences in the rate of absorption between the oral and rectal dosage forms may also be estimated by following the plasma concentrations of salicylic acid during the first 90 minutes after administration. Such a comparison is possible, since acetylsalicylic acid is rapidly deacetylated to salicylic acid. In addition it is not possible to estimate the extent of acetylsalicylic acid absorption by following acetylsalicylic acid plasma concentrations, since a substantial first pass 
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In=7) Fig. 6b , Mean plasma concentrations of salicylic acid (SA) after oral and rectal administration of 500 mg acetylsalicylic acid (ASA) in different dosage forms. Rectal administration of calcium acetylsalicylate (Ca-ASA), dissolved in IO ml of medium, was included in the study. metabolism was reported to occur (ROWLAND et al. 1972) . Due to the relatively slow absorption of acetylsalicylic acid from rectal dosage forms and its subsequent rapid hydrolysis only small amounts of unchanged drug will prevail in the general circulation. This could partly be the consequence of first pass metabolism and support earlier findings with paracetamol that such a first pass effect following rectal administration depends on the rate of uptake of the drug under study from the rectum (MOOLENAAR et aL I979c ). With respect to the first pass effect we concluded from a rectal study with sodium benzoate, that the supposed advantage of the rectal route to bypass the liver is doubtful in the case that biotransformation is rapid relative to absorption (MOOLENAAR et al. 1978 ).
In conclusion: the absolute rate of acetylsalicylic acid uptake in man can only be reliably established from acetylsalicylic acid plasma concentrations. However, differences in rate of absorption after the use of different dosage forms, can be approached by measuring salicylic acid plasma concentrations. The total amount of acetylsalicylic acid absorbed can then be determined comparing the areas under the salicylic acid curves. However, the amounts of acetylsalicylic acid, reaching the circulation intact, can be only determined following acetylsalicylic acid plasma levels.
THERAPEUTIC CONSIDERATIONS
Acetylsalicylic acid produces a pharmacological response which is different from that of salicylic acid. For instance there is considerable evidence that acetylsalicylic acid is a more potent analgesic than salicylic acid (LESTER et al. 1946; ~R~OLIN 1960; LASAGNA 1961; HOUDE et al. 1965; L~ et al. 1967) . BYWATERS (1963) and DUTHm (1963) expressed the view that acetylsalicylic acid is superior to salicylic acid as an anti-inflammatory agent. SEED (1965) has shown that acetylsalicylic acid is a more potent antipyretic than salicylic acid when administered in equimolar ,doses. This would imply that especially in the case of single dose therapy acetylsalicylic acid plasma levels are' prefr erable to those of the metabolite sa,licylic a~id..
Our results indicate that acetylsalicylic acid levels after administration of a rectal micro -~ enema (20 ml, pH 4.0) may approach the acetylsalicylic acid c.oncentrations i,n plasma obtained after oral administration of a solution. On the other hand it appears that using fatty suppositories with an optimized particle size, a rate and extent of acetylsalicylic acid absorption is obtained, which is much less when compared with an equivalent oral dose. This contrasts the findings of PARROT (1971) and others who concluded that rectal and oral doses of acetylsalicylic acid may result in similar absorption characteristics. The authors based their opinions upon the urinary salicylic acid elimination. However, as discussed above, the use of plasma (urine) concentrations of the metabolite salicylate in order to evaluate the absorption of acetylsalicylic acid into the general circulation is not adequate, since a sub, stantial first pass effect may occur. With respect to the dissolution rate-limited character of acetylsalicylic acid it is important to note that it is useless to increase the dose in the rectal dosage form in order to increase absorption rate.
On the contrary, increasing the volume of the rectal dosage form may result in a larger release area, thereby favouring the absorption rate. Rectal administration of (acetyl)salicylic acid may be an attractive alternative for the patient to the massive oral doses given for-the relief of inflammatory conditions frequently leading to nausea or even more severe gastric disturbances (SENIOR 1974) .
In view of the slow and erratic rectal absorption of acetylsalicylic acid from fatty suppositories, rectal administration of sodium salieylate seems a more rational choice. Figure 7 shows the mean plasma concentrations after an oral dose of 500 mgacetylsalicylic acid and an equimolar rectal dose (431 mg) of sodium salicylate, suspended in cocoa butter (4 ml)"to seven Volunteers.
It is important to recall that coarse particles of sodium salicylate have to be chosen in order 114-1979 Pharrnaceutisch Weekblad ~4~6,7, to establish an optimal release of the drug from the suppository base (SCHOONEN et al. z979 ). The effect of particle size reduction on in vivo release of sodium salicylate is evident (Fig. 7) , and clearly contrasts with the effect on acetylsalicylic acid release. In conclusion it can be said that chronic rectal administration of sodium salicylate in fatty suppositories, may be considered as a rational therapy in arthritic patients.
CONCLUSIONS
Compared with the oral route of administration, absorption of acetylsalicylic acid after rectal administration can be equally rapid. However, in view of the limited rectal absorption surface and the unfavourable rectal lumen pH in relation to the pK~, only an optimized aqueous micro-enema (20 ml, pH 4.0) can compete with an orally administered solution.
Since absorption of acetylsalicylic acid from a relatively basic solution is unfavourable, rectal absorption of calcium acetylsalicylate occurs very slowly. In the case of fatty suppositories, particle size reduction favours the rate of acetylsalicylic acid absorption. However, absorption proceeds significantly (P < 0.05) slower compared with oral administration. An increase of the dose in the rectal dosage forms S. __AA plasma conc(ug.mt -1 ), Fig. 7 . Mean plasma concentrations of salicylic acid (SA) after oral administration of 500 mg acetylsalicylic acid (ASA) and after rectal administration of 43 z mg sodium salicylate (Na-sA) suspended in cocoa butter suppositories (4 ml) with different particle sizes, to seven'
volunteers.
x----x oral ASA, 500rag Tn200m[ -_ -_ rectal NASA, 431 mg 125-250~rn in supp. c~ -o rectalNa~qAj/,31 mg <20p...mm in supp.
will not result in a higher absorption rate. Only the volume of the fatty vehicle in which acetylsalicylic acid is suspended, determines the total driving force in absorption. For all rectal dosage forms the extent to which acetylsalicylic acid reaches the general circulation intact, is smaller than after oral administration. From the point of view of therapeutics it is concluded that in single dose therapy with acetylsalicylic acid, if rapid analgesia is desired, an oral solution of the drug under study should generally be preferred to rectal dosage forms. For rectal use, a micro-enema with an acid pH is advantageous, if an optimal absorption rate is desired. If the suppository is chosen as dosage form, the use of small particles promotes the absorption rate of acetylsalicylic acid. It is important to choose the proper size for the suppository to guarantee an optimal absorption surface. In adults a 4 ml mass seems to be convenient, rather than 2 or 3 ml vehicles.
Chronic rectal administration of sodium salicylate (I25 -250 #m) in fatty suppository results in adequate absorption for rectal antiinflammatory therapy.
